BIOMAT Database Logo BIOMAT Database Logo

Clinical and laboratory experiences with cycloserine. 1970

E Jancík, and I Boucková, and M Janciková, and M Novák

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003523 Cycloserine Antibiotic substance produced by Streptomyces garyphalus. R-4-Amino-3-isoxazolidinone,Seromycin
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

E Jancík, and I Boucková, and M Janciková, and M Novák
[Clinical experiences with d-cycloserine].
April 1958, Therapie der Gegenwart,
E Jancík, and I Boucková, and M Janciková, and M Novák
[Experiences with cycloserine].
January 1958, Tuberkuloza,
E Jancík, and I Boucková, and M Janciková, and M Novák
Laboratory investigations with cycloserine.
August 1957, Tuberculology and thoracic diseases,
E Jancík, and I Boucková, and M Janciková, and M Novák
[Experiences with cycloserine therapy].
May 1960, Tuberkulozis,
E Jancík, and I Boucková, and M Janciková, and M Novák
Laboratory and clinical experiences with glutethimide.
January 1960, Anesthesiology,
E Jancík, and I Boucková, and M Janciková, and M Novák
Clinical and laboratory experiences with cephaloridine.
August 1967, Postgraduate medical journal,
E Jancík, and I Boucková, and M Janciková, and M Novák
Clinical and laboratory experiences with ampicillin ("Penbritin").
September 1962, The Medical journal of Australia,
E Jancík, and I Boucková, and M Janciková, and M Novák
CLINICAL AND LABORATORY EXPERIENCES WITH CLOXACILLIN ("ORBENIN").
September 1963, The Medical journal of Australia,
E Jancík, and I Boucková, and M Janciková, and M Novák
Clinical and laboratory experiences with selective thrombolysis.
January 1984, Annales de radiologie,
E Jancík, and I Boucková, and M Janciková, and M Novák
Some laboratory and clinical experiences with erythromycin.
October 1953, Antibiotics & chemotherapy (Northfield, Ill.),
Copied contents to your clipboard!